---
title: "Multicenter, randomized, double-blind, parallel-group clinical trial to evaluate the efficacy and safety of Safinamide versus Rasagiline in fatigue associated with Parkinson's Disease."
euct_id: 2023-503713-29-00
status: Recruiting
sponsor: Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
canonical_url: "https://parkinsonspathways.com/trials/eu/2023-503713-29-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2023-503713-29-00"
ctis_last_updated: "2025-07-24T03:31:09.212328582"
source: EU Clinical Trials Information System (CTIS)
---
# Multicenter, randomized, double-blind, parallel-group clinical trial to evaluate the efficacy and safety of Safinamide versus Rasagiline in fatigue associated with Parkinson's Disease.

**EU CT Number:** [2023-503713-29-00](https://euclinicaltrials.eu/ctis-public/view/2023-503713-29-00)

## Key Facts

- **Status:** Recruiting
- **Sponsor:** Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
- **Start Date:** 2023-09-01
- **Completion Date:** 2025-02-01
- **Conditions:** Fatigue symptoms associated with Parkinson´s Disease.
- **Interventions:** SAFINAMIDE, RASAGILINE

## Member States

Trial is authorized in 1 member state: Spain.

## Sites (10)

- Complexo Hospitalario Universitario A Coruna, A Coruna, Spain
- Hospital Universitario Virgen De Las Nieves, Granada, Spain
- Hospital General Universitario De Elche, Elche, Spain
- Hospital Clinico San Carlos, Madrid, Spain
- Hospital De La Santa Creu I Sant Pau, Barcelona, Spain
- Hospital General Universitario Santa Lucia, Cartagena, Spain
- Hospital Universitario Donostia, Donostia, Spain
- Hospital Universitario De Cruces, Barakaldo, Spain
- Hospital Universitari Dexeus Grupo Quironsalud, Barcelona, Spain
- University Hospital Virgen Del Rocio S.L., Sevilla, Spain

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Fatigue symptoms associated with Parkinson´s Disease.
Age groups: elderly 65+, adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2023-503713-29-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2023-503713-29-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2023-503713-29-00*